Rockwell Medical (RMTI) Operating Expenses (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Operating Expenses came in at $4.4 million in Q1 2026, down 0.57% YoY from $4.4 million in Q1 2025, and up 2.36% on a QoQ basis from $4.3 million in Q4 2025.
Rockwell Medical (RMTI) Operating Expenses (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Operating Expenses data on file, last reported at $4.4 million in Q1 2026.
- Quarterly Operating Expenses fell 0.57% year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.4 million (down 12.87% YoY) and the FY2025 annual result came in at $16.4 million, down 2.79% from the prior year.
- Operating Expenses grew to $4.4 million in Q1 2026, from $4.3 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $6.0 million in Q4 2024 to a low of $2.9 million in Q4 2023.
- A 5-year average of $4.1 million and a median of $4.0 million in 2024 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses plunged 31.34% — and 2024, when it surged 110.42%.
- Tracing RMTI's Operating Expenses over 5 years: stood at $2.9 million in 2022, then declined by 2.08% to $2.9 million in 2023, then surged by 110.42% to $6.0 million in 2024, then fell by 29.17% to $4.3 million in 2025, then gained by 2.36% to $4.4 million in 2026.
- The last three Operating Expenses figures came in at $4.4 million (Q1 2026), $4.3 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Rockwell Medical | 29.69 Mn | 4.89 Mn | 3.24 Mn | 4.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.26 Mn |
| Mar 31, 2026 | 4.38 Mn |
| Dec 31, 2025 | 4.28 Mn |
| Sep 30, 2025 | 3.86 Mn |
| Jun 30, 2025 | 3.85 Mn |
| Mar 31, 2025 | 4.40 Mn |
| Dec 31, 2024 | 6.04 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Jun 30, 2024 | 4.04 Mn |
| Mar 31, 2024 | 4.37 Mn |
| Dec 31, 2023 | 2.87 Mn |
| Sep 30, 2023 | 3.38 Mn |
| Jun 30, 2023 | 3.83 Mn |
| Mar 31, 2023 | 3.53 Mn |
| Dec 31, 2022 | 2.93 Mn |
| Sep 30, 2022 | 3.72 Mn |
| Jun 30, 2022 | 5.30 Mn |
| Mar 31, 2022 | 4.27 Mn |
| Dec 31, 2021 | 4.15 Mn |
| Sep 30, 2021 | 5.42 Mn |